Studies related to Blood Flow and Hesperidin

Bioavailability Of Orally Administered Water-dispersible Hesperetin And Its Effect On Peripheral Vasodilatation In Human Subjects: Implication Of Endothelial Functions Of Plasma Conjugated Metabolites

Effect Increase
Trial Design Cohort
Trial Length 24 hours
Number of Subjects 9
Sex Both Genders
Age Range 30-44, 45-64
Body Types Average
Notes for this study:
A water soluble variant of Hesperidin of 150mg (or standard hesperitin at 150mg) was able to improve blood flow as assessed by temperature changes in the body with external cold water tests.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.